TNSN07424A1 - Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l'eugenol, le borneol et le carvacrol - Google Patents

Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l'eugenol, le borneol et le carvacrol

Info

Publication number
TNSN07424A1
TNSN07424A1 TNP2007000424A TNSN07424A TNSN07424A1 TN SN07424 A1 TNSN07424 A1 TN SN07424A1 TN P2007000424 A TNP2007000424 A TN P2007000424A TN SN07424 A TNSN07424 A TN SN07424A TN SN07424 A1 TNSN07424 A1 TN SN07424A1
Authority
TN
Tunisia
Prior art keywords
active substance
carveol
carvacrol
borneol
thymol
Prior art date
Application number
TNP2007000424A
Other languages
English (en)
French (fr)
Inventor
Adnane Remmal
Original Assignee
Advanced Scient Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Scient Dev filed Critical Advanced Scient Dev
Publication of TNSN07424A1 publication Critical patent/TNSN07424A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TNP2007000424A 2005-05-13 2007-11-13 Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l'eugenol, le borneol et le carvacrol TNSN07424A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2005/001313 WO2006120494A1 (fr) 2005-05-13 2005-05-13 Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l’eugenol, le borneol et les carvacrol
PCT/IB2006/001350 WO2006120567A2 (fr) 2005-05-13 2006-05-15 Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l'eugenol, le borneol et le carvacrol

Publications (1)

Publication Number Publication Date
TNSN07424A1 true TNSN07424A1 (fr) 2009-03-17

Family

ID=35427275

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2007000424A TNSN07424A1 (fr) 2005-05-13 2007-11-13 Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l'eugenol, le borneol et le carvacrol

Country Status (13)

Country Link
US (1) US20080214518A1 (enExample)
EP (1) EP1879655B1 (enExample)
JP (1) JP5410748B2 (enExample)
CN (3) CN101175531B (enExample)
BR (1) BRPI0610125B8 (enExample)
CA (1) CA2606875C (enExample)
DK (1) DK1879655T3 (enExample)
EA (1) EA014069B1 (enExample)
ES (1) ES2530963T3 (enExample)
MA (1) MA29606B1 (enExample)
PT (1) PT1879655E (enExample)
TN (1) TNSN07424A1 (enExample)
WO (2) WO2006120494A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2918571B1 (fr) * 2007-07-10 2013-01-11 Aroma Tech Compositions antibiotiques a base d'huiles essentielles prophylaxie et traitement d'infections nosocomiales
NZ585620A (en) 2007-10-26 2013-03-28 Ca Nat Research Council Compositions and methods for enhancing immune response
FR2925334A1 (fr) * 2007-12-21 2009-06-26 Ceva Sante Animale Sa Nouvelles compositions antibacteriennes
WO2010124391A1 (en) 2009-04-30 2010-11-04 Chemaphor Inc. Methods and compositions for improving the health of animals
PH12012500494A1 (en) 2009-09-24 2012-10-22 Unilever Nv Disinfecting agent comprising eugenol, terpineol and thymol
EP2648681B1 (en) 2010-12-07 2015-01-07 Unilever N.V. An oral care composition
IN2014MN00808A (enExample) 2011-11-03 2015-09-04 Unilever Plc
MX347858B (es) 2011-12-06 2017-05-16 Unilever Nv Composición antimicrobiana.
CN102670598B (zh) * 2012-05-08 2014-07-16 广东药学院 一种青霉素冰片组合物在制备抗菌药物中的应用
CN102670619B (zh) * 2012-05-08 2014-02-19 广东药学院 一种头孢氨苄冰片组合物
CN103146255B (zh) * 2013-02-25 2014-07-09 厦门吉宏包装科技有限公司 一种抑菌驱螨印刷底油母液和由母液制作的印刷底油及其制备方法
BR112015027837A2 (pt) * 2013-05-07 2017-08-29 Kemin Ind Inc Combinação de extratos de planta usada como um aditivo para ração
FR3025718A1 (fr) 2014-09-15 2016-03-18 Septeos Antimicrobiens potentialises
FR3025719A1 (fr) 2014-09-15 2016-03-18 Septeos Antimicrobiens potentialises
US10780294B2 (en) 2014-11-19 2020-09-22 The General Hospital Corporation System and method for photo-dynamic procedure
HRP20201828T1 (hr) * 2014-12-18 2021-01-08 Helperby Therapeutics Limited Nova kombinacija i uporaba
EP3233069A1 (en) * 2014-12-18 2017-10-25 Helperby Therapeutics Limited Antimicrobial combinations and their use in the treatment of microbial infection
CN109512998A (zh) * 2016-03-04 2019-03-26 广州英赛特生物技术有限公司 含氧碳氢衍生物的酯化衍生物作为多粘菌素的协同增效剂的应用
FR3048612B1 (fr) * 2016-03-14 2020-10-02 Septeos Tulathromycine potentialisee
WO2017209588A2 (fr) 2016-06-02 2017-12-07 Advanced Scientific Developements Formulation pharmaceutique de cinéol et d'amoxicilline
GB201904963D0 (en) * 2019-04-08 2019-05-22 Anpario Plc Composition for reducing antimicrobial resistance
WO2021110915A1 (fr) 2019-12-04 2021-06-10 Pranarôm International S.A. Procede de transformation d'une huile essentielle
KR102848354B1 (ko) * 2023-02-13 2025-08-21 경상국립대학교산학협력단 테트라사이클린계 항생제와 시너지 효과를 가지는 바닐린 또는 카바크롤을 유효성분으로 포함하는 조성물 및 이의 용도

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4317775A (en) * 1980-01-07 1982-03-02 Hoffmann-La Roche Inc. Amoxicillin derivatives
DE3634697A1 (de) * 1986-10-11 1988-04-21 Dentaire Ivoclar Ets Dentalwerkstoff zur bekaempfung von karies und parodontose
US5213615A (en) * 1986-10-11 1993-05-25 Ivoclar Ag Dental material and method for the control of caries and paradentitis
US5801153A (en) * 1991-09-13 1998-09-01 Badaway; Mohammed A. Method of enhancing the antimicrobial properties of antibacterial antibiotics to massively control and prevent bacterial, fungal, and viral diseases in plants
FR2697133B1 (fr) * 1992-10-28 1995-01-13 Transbiotech Composition biocide et/ou biostatique et ses applications.
US5308873A (en) * 1992-12-18 1994-05-03 Doyle E. Chastain Method of killing yeast and fungi with carveol
WO1996040192A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US5716928A (en) * 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US6319507B1 (en) * 1997-05-02 2001-11-20 Kobo Products, Inc. Agar gel bead composition and method
US6025400A (en) * 1998-08-24 2000-02-15 Marco Polo Technologies Compositions for treatment of antibiotic-resistant gram-positive bacterial infections and methods for using and preparing the same
SE9901733L (sv) * 1999-05-12 2000-11-13 Akzo Nobel Nv En komposition innehållande karvakrol och tymol för användning som bactericid
US6414036B1 (en) * 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
US6495512B1 (en) * 2000-06-23 2002-12-17 International Flavors & Fragrances Inc. Salicylaldehyde-containing composition having antimicrobial and fragrancing properties and process for using same
US20020103261A1 (en) * 2000-10-06 2002-08-01 Dusan Ninkov Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
US20030064948A1 (en) * 2001-02-08 2003-04-03 Alfred Fahr Invasomes for therapy of disorders, their preparation and use
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US20030180349A1 (en) * 2001-12-07 2003-09-25 Franklin Lanny U. Respiratory infection prevention and treatment with terpene-containing compositions
US20030225003A1 (en) * 2002-04-18 2003-12-04 Dusan Ninkov Antimicrobial therapeutic compositions for oral and topical use
AU2003282358A1 (en) * 2002-11-21 2004-06-15 J.P.M.E.D. Ltd. Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil
CA2508796A1 (en) * 2002-12-10 2004-06-24 Biosynexus Incorporated Topical anti-infective formulations
US20040151771A1 (en) * 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
ES2434415T3 (es) * 2004-05-20 2013-12-16 Eden Research Plc Composiciones que contienen una partícula hueca de glucano o una partícula de pared celular encapsulando un componente de terpeno, métodos para su fabricación y utilización.

Also Published As

Publication number Publication date
CN103356612A (zh) 2013-10-23
EP1879655B1 (fr) 2014-11-26
JP5410748B2 (ja) 2014-02-05
WO2006120494A1 (fr) 2006-11-16
WO2006120567A2 (fr) 2006-11-16
EP1879655A2 (fr) 2008-01-23
ES2530963T3 (es) 2015-03-09
EA014069B1 (ru) 2010-08-30
WO2006120567A3 (fr) 2007-08-23
CN103356612B (zh) 2015-04-15
CN101175531B (zh) 2011-09-07
CN102319246B (zh) 2013-07-17
BRPI0610125B8 (pt) 2021-05-25
CA2606875A1 (fr) 2006-11-16
US20080214518A1 (en) 2008-09-04
PT1879655E (pt) 2015-02-24
JP2008540507A (ja) 2008-11-20
MA29606B1 (fr) 2008-07-01
EA200702483A1 (ru) 2008-04-28
CN102319246A (zh) 2012-01-18
DK1879655T3 (en) 2015-02-23
BRPI0610125B1 (pt) 2020-08-11
CN101175531A (zh) 2008-05-07
BRPI0610125A2 (pt) 2012-09-25
CA2606875C (fr) 2015-12-15

Similar Documents

Publication Publication Date Title
TNSN07424A1 (fr) Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l'eugenol, le borneol et le carvacrol
TNSN07425A1 (fr) Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol,l'eugenol, le thymol, le borneol, le carvacrol, et les ionones alpha-et-beta-.
TNSN07423A1 (fr) Composition pharmaceutique comprenant un agent antiparasitaire, et un actif choisi parmi le carveol, le thymol, l'eugenol, le borneol, le carvacrol, l 'alpha-ionone ou le beta-ionone
WO2003105800A3 (de) Filmförmige mucoadhäsive darreichungsformen zur verabreichung von cannabis-wirkstoffen
MA30504B1 (fr) Compositions pharmaceutiques stabilisees comprenant de la fesoterodine
BRPI0409250A (pt) composições farmacêuticas sólidas compreendendo um agonista receptor de s1p e um álcool do açúcar
EA200500289A1 (ru) Арилзамещенные бензимидазолы и их использование в качестве блокаторов натриевых каналов
PT994710E (pt) Composicoes farmaceuticas administraveis por via oral incluindo uma benzidrilpiperazina e uma ciclodextrina
CA2176840A1 (fr) Association d'un compose a activite anti-microbienne et d'un monoalkylether de glycerol
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
MXPA03008756A (es) Derivados de n-(arilsulfonil) beta-aminoacidos que comprenden un grupo aminometilo substituido, el metodo de preparacion de los mismos y las composiciones farmaceuticas que los contienen.
WO2004112696A3 (en) Methods and compositions for delivery of catecholic butanes for treatment of diseases
TNSN08152A1 (fr) Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation
MA29969B1 (fr) Formulations de quinolinones
MA29723B1 (fr) Composes
WO2005117895A8 (en) Compositions comprising meloxicam
MXPA05008960A (es) Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen.
DK1408966T3 (da) Synergistiske farmaceutiske kombinationer til forebyggelse eller behandling af diabetes
NO20064808L (no) Orale matrixformuleringer med licarbazepin
MA32128B1 (fr) Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artémisinine ou l'un de ses derives pour le traitement du paludisme severe
BRPI0206841B8 (pt) aplicação de depsipeptídeo cíclico
WO2007011958A3 (en) Intraoral dosage forms of glucagon
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
BRPI0409170A (pt) combinações compreendendo drogas antiepilépticas para o tratamento de distúrbios neurológicos
MA58128B1 (fr) Composition de furazidine à libération prolongée